03 October 2022>: Clinical Research
Effect of Vitamin D Concentration on Course of COVID-19
Magdalena Dominika Szerszeń 12ABDEF* , Aleksandra Kucharczyk 1BDEF , Katarzyna Bojarska-Senderowicz 1BDE , Monika Pohorecka 12ADE , Andrzej Śliwczyński 3CD , Janusz Engel 4C , Tomasz Korcz 5B , Dariusz Kosior 6A , Irena Walecka 7A , Wojciech Stefan Zgliczyński 8A , Waldemar Wierzba 910G , Adam Jerzy Sybilski 12ADFDOI: 10.12659/MSM.937741
Med Sci Monit 2022; 28:e937741
Table 1 Vitamin D level in the study population.
Vitamin D level | COVID-19 (+) | COVID-19 (−) | ||||
---|---|---|---|---|---|---|
Male | Female | Total | Male | Female | Total | |
Optimal (>30 ng/ml) | 11 | 25 | 36 (19.4%) | 26 | 39 | 65 (20.4%) |
Suboptimal (20–30 ng/ml) | 6 | 26 | 32 (17.2%) | 39 | 32 | 71 (22.3%) |
Deficiency ( | 76 | 42 | 118 (63.4%) | 98 | 85 | 183 (57.4%) |